发明名称 |
1,8-Naphthyridine derivatives and their use to treat diabetes and related disorders |
摘要 |
The invention relates generally to naphthyridine derivatives of the formula wherein one of U, X, Y and Z is nitrogen and the others are C-R, where R is hydrogen or a substituent. More specifically, the invention relates to 1,8-naphthyridine derivatives and pharmaceutical compositions containing such derivatives. Methods of the invention comprise administration of a naphthyridine derivative of the invention for the treatment of diabetes and related disorders.
|
申请公布号 |
US6900205(B2) |
申请公布日期 |
2005.05.31 |
申请号 |
US20020253104 |
申请日期 |
2002.09.23 |
申请人 |
BAYER PHARMACEUTICALS CORPORATION |
发明人 |
WANG YAMIN;BULLOCK WILLIAM H.;GUNN DAVID E.;LIU QINGJIE;LIANG SIDNEY X.;LIU DONGLEI;MAGNUSON STEVEN R.;LI TINDY;MULL ERIC S.;WOOD JILL E.;QI NING |
分类号 |
A61K31/133;A61K31/155;A61K31/195;A61K31/198;A61K31/435;A61K31/4375;A61K31/44;A61K31/4439;A61K31/444;A61K31/445;A61K31/4453;A61K31/4545;A61K31/455;A61K31/4709;A61K31/4725;A61K31/4745;A61K31/496;A61K31/5355;A61K31/5377;A61K31/541;A61K31/64;A61K31/7034;A61K38/22;A61K38/28;A61K45/00;A61K45/06;A61P3/04;A61P3/10;A61P5/12;A61P5/42;A61P9/12;A61P35/00;A61P37/06;A61P43/00;C07D471/02;C07D471/04;(IPC1-7):A61K31/537;C07D413/14 |
主分类号 |
A61K31/133 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|